To evaluate the efficacy of either a 1550nm non-ablative fractional laser or a 1927nm thulium fractional laser in the treatment of female pattern hair loss (FPHL).
Adult women aged 35-65 years
Fitzpatrick skin types I-IV
Presence of female pattern hair loss of the frontal or vertex of scalp (Sinclair (II-IV)
Must be willing and can comply with all study protocols, including all treatment schedules, follow up visit, assessments, sign a photography release and ICF, and complete the entire course of the study
No surgery, pregnancy, breast feeding, change in or addition of hormonal contraception in the last 6 months
No history of iron deficiency anemia, vitamin D deficiency, or thyroid disease (hypothyroidism or hyperthyroidism or currently on thyroid supplementation)
Use of scalp light or with laser treatment within the last 6 months.
Use of topical or systemic drugs affecting hair growth within 6 months prior to enrollment (such as oral spironolactone, finasteride, oral or topical minoxidil, and supplements marketed for hair growth such as Nutrafol)